Purdue Pharma and its subsidiaries are physician-founded and physician-led companies that develop, manufacture and market medications and consumer health products to meet the …

Purdue and its subsidiaries are pioneers in medical science with a patient-first approach in developing prescription and non-prescription medications. We focus on balancing innovative …

Purdue Pharma and its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients and caregivers. Purdue’s plan of …

Purdue is a pioneer in healthcare, with a patient-first approach in developing medicines. We combine medical science with compassionate care in every phase of drug research and …

STAMFORD, Conn., Sept. 30, 2024 – Purdue Pharma has completed the first phase of a study examining the use of nalmefene hydrochloride (HCI) injection in real-world emergency …

Purdue Pharma develops and provides prescription medicines that meet the evolving needs of healthcare professionals, patients, and caregivers. For decades, we have developed …

Purdue continues to work tirelessly with creditors to reach a new settlement that delivers billions of dollars of value for opioid abatement and allows the Company to emerge from bankruptcy …

Oct 28, 2024 · Purdue Pharma distributes, for no profit, nalmefene injection in a 2mg/2mL (1mg/1mL) vial, as part of the Company’s commitment to providing opioid overdose treatments …

May 6, 2024 · Purdue Pharma and its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients, and caregivers. Purdue’s …

STAMFORD, Conn., April 08, 2024 – Purdue Pharma L.P. (“Purdue”) announced today that FDA has accepted for filing the company’s New Drug Application (NDA) for the auto-injector …